1 Step forward, 2 steps back: with hopes of a new osteoarthritis treatment dashed after FDA rejection of the latest COX-2 drug, some OA patients - and doctors - are downright angry

Subjects

Subjects :

COX-2 inhibitors -- Complications and side effects
Drug approval -- Evaluation
Osteoarthritis -- Care and treatment
Health

Details

Language :

English

ISSN :

08901120

Volume :

21

Issue :

4

Database :

Gale General OneFile

Journal :

Arthritis Today

Publication Type :

Periodical

Accession number :

edsgcl.166174289